Open Mic Showcase Continues Highlight the Talents of Cancer Survivors

Video

The second installment of CURE®’s Open Mic Showcase features cancer survivors performing original songs, showcasing a handmade deck of cards and reading poetry.

Research has shown that art can help ease psychological distress in patients with cancer — it can also help patients connect with others who may be going through a similar experience. In light of fostering that connection for survivors, CURE® launched its first Open Mic Showcase, where patients, survivors and caregivers showed their talent — from original songwriting to poetry reading and more — in an act that relates to their cancer experience.

This is the second of three installments of the Open Mic Showcase. If you missed the first, find it here: Open Mic Showcase Debut Puts Cancer Survivors, Patients in the Spotlight

(0:48) Our first video of the day comes from Nancy King, who wrote and performed a song, “Cry Cry My Heart, But Do Not Break.” After being diagnosed with bladder cancer in 2021, she said she underwent seven surgeries and 15 Bacillus Calmette Guerin (BCG) treatments. The song is reflective of her experience.

(5:01) The second performance is from Michelle Gauer, a psychic medium, author and stage 4 lung cancer survivor.

Michelle created a 44-card deck of cards that reflected the themes of what she went through during her cancer experience. She hopes that the cards will provide spiritual guidance and support to others who are going through similar experiences.

(8:58) Next John Smelcer, a non-Hodgkin lymphoma survivor and CURE® contributor, read two poems from his poetry collection, “Running from the Reaper” about his experience with stage 2 disease.

(12:27) In the spirit of CURE® contributors and poets, another one of our bloggers, Felicia Mitchell, will read her poem, “Bald Felicia” about a mother-daughter duo’s experience. In the poem, the daughter is imagining what might have gone on in her mother’s head late in her journey with dementia, while the daughter, meanwhile, is going through cancer.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Related Content